Abstracts tagged "Juvenile Arthritis"

Abstract Number: 955 • 2015 ACR/ARHP Annual Meeting
Cancer Risk in 5,108 Patients with Juvenile Idiopathic Arthritis (JIA)
Omid Zahedi Niaki¹, Ann E. Clarke², Rosalind Ramsey-Goldman³, Rae S.M. Yeung⁴, Kristen Hayward⁵, Kiem Oen⁶, Ciarán M. Duffy⁷, Alan M. Rosenberg⁸, Kathleen O'Neil⁹, Emily von Scheven¹⁰, Laura Schanberg¹¹, Jeremy Labrecque¹², Jennifer LF Lee¹³ and Sasha Bernatsky¹⁴, ¹Medicine, McGill University, Montreal, QC, Canada, ²Immunology/Epidemiology, Montreal General Hospital, Montreal, QC, Canada, ³Northwestern University Feinberg School of Medicine, Chicago, IL, ⁴Pediatrics, Immunology and Medical Science, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, ⁵Pediatric Rheumatology, University of Washington & SCH, Seattle, WA, ⁶Department of Pediatrics and Child Health, University of Manitoba; Head, Section of Pediatric Rheumatology, Children’s Hospital, University of Manitoba, The Children`s Hospital Foundation of Manitoba, Winnipeg, MB, Canada, ⁷Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, ⁸Pediatrics, University of Saskatchewan, Saskatoon, SK, Canada, ⁹Pediatric Rheumatology, RIley Hospital for Children, Indianapolis, IN, ¹⁰Dept of Pediatric Rheumatology, Univ of California San Francisco, San Francisco, CA, ¹¹Pediatrics, Duke Medical Center, Durham, NC, ¹²Clinical Epidemiology, McGill UHC/RVH, Montreal, QC, Canada, ¹³Clinical Epidemiology Rheum, McGill UHC/RVH, Montreal, QC, Canada, ¹⁴Rheum/Clin. Epid., McGill MUHC/RVH, Montreal, QC, Canada
Background/Purpose: Given suspected links between inflammation and malignancy, several groups have attempted to elucidate the baseline risk of cancer in various inflammatory or autoimmune conditions, including rheumatoid arthritis,…
Abstract Number: 1389 • 2015 ACR/ARHP Annual Meeting
A Meta-Analysis of the Prevalence of the Ocular Manifestations in All Inflammatory Rheumatic Diseases
Jacqueline Hayworth¹ and Janet E. Pope², ¹Medicine, University of Western Ontario and U of Toronto, Toronto, ON, Canada, ²University of Western Ontario, London, ON, Canada
Background/Purpose: Many inflammatory rheumatic diseases (IRD) are associated with ocular involvement. The prevalence of these complications is not fully known. This meta-analysis was performed to…
Abstract Number: 1480 • 2015 ACR/ARHP Annual Meeting
Adiposity in Children with Juvenile Psoriatic Arthritis (JPsA)
Aaida Samad¹, Matthew L. Stoll², Idit Lavi³, Kriti Gupta¹, Joyce Hsu⁴, Vibeke Strand^5,6, Elizabeth D. Mellins⁷, Devy Zisman⁸ and for the CARRA Registry Investigators, ¹Dept of Pediatrics CSSR, Stanford University Med Ctr, Stanford, CA, ²University of Alabama at Birmingham, Birmingham, AL, ³Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel, ⁴Pediatric Rheumatology, Stanford University, Palo Alto, CA, ⁵Stanford University, Palo Alto, CA, ⁶Biopharmaceutical Consultant, Portola Valley, CA, ⁷Dept of Pediatrics CCSR, Stanford University Med Ctr, Stanford, CA, ⁸Rheumatology Unit, Carmel Medical CenterThe Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel, Haifa, Israel
Background/Purpose: To assess the adiposity/BMI of children diagnosed with JPsA in a North American registry, examining differences between overweight and non-overweight patients with regard to…
Abstract Number: 2830 • 2014 ACR/ARHP Annual Meeting
Progression to and Type of Orthopaedic Surgery in Juvenile Vs. Adult-Onset Ankylosing Spondylitis
Deepak R. Jadon¹, Gavin Shaddick², Amelia Jobling³, Athimalaipet V Ramanan⁴ and Raj Sengupta¹, ¹Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, ²Department of Mathematics, University of Bath, Bath, United Kingdom, ³Department of Mathematical Sciences, University of Bath, Bath, United Kingdom, ⁴Paediatric Rheumatology, University of Bristol Hospital Trust, Bristol, United Kingdom
Background/Purpose: Juvenile-onset ankylosing spondylitis (JoAS) and adult-onset ankylosing spondylitis (AoAS) are subtypes of ankylosing spondylitis (AS) that may have different clinical outcome. We compared cohorts…
Abstract Number: 2317 • 2014 ACR/ARHP Annual Meeting
Towards Reliable Implementation and Optimal Use of Medication Decision Aid Cards for Shared Decision Making in Juvenile Idiopathic Arthritis
Esi M. Morgan DeWitt¹, Janalee Taylor², Karla B. Jones³, Murray H. Passo⁴, Catherine C. Mims⁴, Jesse Pratt⁵, Ellen A. Lipstein⁶, Nancy Griffin⁷, Sheetal S. Vora⁸, Beth S. Gottlieb⁹, Elizabeth Roth-Wojcicki¹⁰ and William B. Brinkman¹¹, ¹Department of Pediatrics, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²William S. Rowe Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ³Rheumatology ED 1S, Nationwide Children's Hospital, Columbus, OH, ⁴Pediatric Rheumatology, Medical University of South Carolina, Charleston, SC, ⁵Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁶Division of Adolescent Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁷James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁸University of North Carolina Chapel Hill, Chapel Hill, NC, ⁹Pediatric Rheumatology, Cohen Children's Medical Center of New York, New Hyde Park, NY, ¹⁰Pediatrics, Medical College of Wisconsin, Milwaukee, WI, ¹¹Division of General and Community Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Background/Purpose The purpose of the study was to improve communication and shared decision-making (SDM) between clinicians and parents of patients with juvenile idiopathic arthritis (JIA),…
Abstract Number: 2287 • 2014 ACR/ARHP Annual Meeting
Cartilage Thickness and Bone Health in Children with Juvenile Idiopathic Arthritis
Marinka Twilt¹, Dan Pradsgaard², Anne Helene Spannow², Arne Horlyck³, Carsten Heuck² and Troels Herlin⁴, ¹Paediatrics, Aarhus University Hospital, Aarhus, Denmark, ²paediatrics, Aarhus University Hospital, Aarhus, Denmark, ³radiology, Aarhus University Hospital, Aarhus, Denmark, ⁴Pediatric Rheumatology Clinic, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
Background/Purpose Although treatment options have increased and morbidity has decreased in the last decade Juvenile Idiopathic Arthritis (JIA) may still result in disability. Increasingly ultrasonography…
Abstract Number: 298 • 2014 ACR/ARHP Annual Meeting
Long-Term Impact of Juvenile Idiopathic Arthritis in the Greek adults’ Psychosocial Life
Despoina Dimopoulou¹, Maria Trachana², Polyxeni Pratsidou-Gertsi³, George Garyfallos⁴, Prodromos Sidiropoulos⁵, Athina Theodoridou⁶ and Alexandros Garyfallos⁶, ¹Nikolaou Manou Str. 20, 4th Department of Internal Medicine, Aristotle University, Hippocratio Hospital, Thessaloniki, Greece, ²Aristotle University, Thessaloniki, Greece, ³1st Department of Pediatrics, Aristotle University, 1st Department of Pediatrics, Aristotle University, Thessaloniki, Greece, ⁴2nd Department of Psychiatry Aristotle University, 2nd Department of Psychiatry Aristotle University, Thessaloniki, Greece, ⁵Rheumatology, Clinical Immunology, and Allergy, University of Crete, Heraklion, Greece, ⁶4th Department of Internal Medicine, Aristotle University, Hippocratio Hospital, 4th Department of Internal Medicine, Aristotle University, Hippocratio Hospital, Thessaloniki, Greece
Background/Purpose Juvenile idiopathic arthritis (JIA) seems to have a negative impact on patients’ life style mostly due to the disease chronicity. No relevant data have been…
Abstract Number: 286 • 2014 ACR/ARHP Annual Meeting
Using the 2011 ACR Recommendations for the Treatment of Juvenile Idiopathic Arthritis (JIA) to Evaluate a Single Centre Treatment Pathway: A Feasibility Study
Katherine Green¹, Marinka Twilt² and Taunton R. Southwood³, ¹Rheumatology, Birmingham Children's Hospital, Birmingham, United Kingdom, ²Paediatrics, Aarhus University Hospital, Aarhus, Denmark, ³Institute of Child Health, University of Birmingham and Birmingham Children's Hospital, Birmingham, United Kingdom
Background/Purpose The 2011 ACR recommendations for the treatment of Juvenile Idiopathic Arthritis (ACR-JIA) are evidence-based, consensus-approved therapeutic pathways for the safe and effective treatment of…
Abstract Number: 285 • 2014 ACR/ARHP Annual Meeting
Drug Safety in Treatment of Juvenile Idiopathic Arthritis (JIA): Biologic Therapy Compared with MTX
Gerd Horneff¹, Hans Huppertz², Gerd Ganser³, Johannes Peter Haas⁴, Ivan Foeldvari⁵ and Kirsten Minden⁶, ¹Asklepios Klinik Sankt Augustin, Sankt Augustin, Germany, ²Prof Hess Children’s Hospital, Bremen, Germany, ³Pediatric Rheumatology, Sankt Josef Stift, Sendenhorst, Germany, ⁴German Center for Pediatric and Adolescent Rheumatology, Garmisch-Partenkirchen, Germany, ⁵Department of Pediatric Rheumatology, Hamburger Zentrum für Kinder und Jugendrheumatologie, Hamburg, Germany, ⁶Epidemiology unit, German Rheumatism Research Center, Berlin, Germany
Background/Purpose Drug surveillance of biologics in juvenile patients using registries is of immense importance as patient numbers and duration in clinical trials are limited. There…
Abstract Number: 2790 • 2013 ACR/ARHP Annual Meeting
The Research In Arthritis In Canadian Children Emphasizing Outcomes (ReACCh Out) Cohort: Are We Achieving Clinically Important Outcomes?
Deborah M. Levy¹, Shirley ML Tse¹, Elizabeth Stringer², Jaime Guzman³, Roberta A. Berard⁴, Karen Watanabe Duffy⁵, Dax Rumsey¹, Mercedes O. Chan³, Rosie Scuccimarri⁶, Adam M. Huber⁷, Lori B. Tucker³, Rae SM Yeung¹, Ciaran M. Duffy⁵, Kiem Oen⁸ and The ReACCh Out Investigators⁹, ¹Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, ²Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada, ³Rheumatology, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, ⁴Children's Hospital of Western Ontario, London, ON, Canada, ⁵Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, ⁶McGill University, Montreal, QC, Canada, ⁷Dalhousie University, Halifax, NS, Canada, ⁸Pediatrics, Children's Hospital of Winnipeg and University of Manitoba, Winnipeg, MB, Canada, ⁹The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada
Background/Purpose: Recent data suggests that achievement of inactive disease and early disease remission may result in improved outcomes for patients with juvenile idiopathic arthritis (JIA). …
Abstract Number: 1891 • 2013 ACR/ARHP Annual Meeting
Proteomic Profile Of Tears: Can It Help To Diagnose Juvenile Arthritis – Associated Uveitis Prior To The Clinical Signs Of Joints Inflammation
Vyacheslav Chasnyk¹, Sergei Nekhai², Alla Hynes³, Tatiana Ammosova⁴, Yuri Obukhov⁴, Ekaterina Gaidar⁵, Anatolyi Kononov⁵, Margarita Dubko⁶, Elena Serogodskaia⁶ and Tatiana Nikitina⁵, ¹Hospital Pediatry, State Pediatric Medical University, Saint-Petersburg, Russia, ²Department of Medicine, Center for Sickle Cell Disease, Howard University, Washington, DC, ³Eye Care Physicians and Surgeons, Winchester, VA, ⁴Howard University, Washington, DC, ⁵Saint-Petersburg State Pediatric Medical University, St. Petersburg, Russia, ⁶State Pediatric Medical University, Saint-Petersburg, Russia
Background/Purpose: Approximately 6% of all cases of uveitis arise in children (Nguyen, Foster, 1998). One of the common causes of uveitis is Juvenile Idiopathic Arthritis…
Abstract Number: 1537 • 2013 ACR/ARHP Annual Meeting
Primary & Subsequent Orthopedic Surgeries More Common In Juvenile Vs. Adult-Onset Ankylosing Spondylitis
Deepak R. Jadon¹, Ramani Arumugam¹, Gavin Shaddick², Alison L Nightingale³, Athimalaipet V Ramanan⁴ and Raj Sengupta¹, ¹Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, ²Department of Mathematics, University of Bath, Bath, United Kingdom, ³Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom, ⁴Paediatric Rheumatology, University of Bristol Hospital Trust, Bristol, United Kingdom
Background/Purpose: Patients experiencing ankylosing spondylitis (AS) symptoms ²16 years-of-age are classified as juvenile-onset AS (JoAS), whilst those ³17 years adult-onset AS (AoAS). We compared JoAS…
Abstract Number: 294 • 2013 ACR/ARHP Annual Meeting
Physical Activity In Children With Juvenile Idiopathic Arthritis (JIA): The LEAP (Linking Exercise, Activity and Pathophysiology in Childhood Arthritis) Study
Lori B. Tucker¹, Heather A. McKay², Leanne M. Ward³, Jaime Guzman¹, Adam Baxter-Jones⁴, Kiem Oen⁵, Alan M. Rosenberg⁶, Johannes Roth³, Elizabeth Stringer⁷, Rae SM Yeung⁸, Kristin M. Houghton⁹, Heather Macdonald¹⁰, Debbie Ehrmann Feldman¹¹, Ciaran M. Duffy¹² and LEAP Study Investigators¹³, ¹Rheumatology, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, ²Family Practice and Orthoepedics, University of British Columbia, Vancouver, BC, Canada, ³University of Ottawa, Ottawa, ON, Canada, ⁴College of Kinesiology, University of Saskatchewan, Saskatoon, SK, Canada, ⁵University of Manitoba, Winnipeg, MB, Canada, ⁶Department of Pediatrics, University of Saskatchewan, Saskatoon, SK, Canada, ⁷Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada, ⁸Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, ⁹University of British Columbia, Vancouver, BC, Canada, ¹⁰The University of British Columbia, Vancouver, BC, Canada, ¹¹Rehabilitation, Université de Montréal, Montreal, QC, Canada, ¹²Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, ¹³BC Children's Hospital, Vancouver, BC, Canada
Background/Purpose: Although children with JIA have lower fitness levels than healthy peers, little is known about their level of habitual physical activity. The LEAP…
Abstract Number: 1150 • 2012 ACR/ARHP Annual Meeting
Adverse Events in Juvenile Idiopathic Arthritis: Results From the Enhanced Drug Safety Surveillance (EDSS) Pilot Project
Sarah Ringold¹, Audrey F. Hendrickson², Carol A. Wallace³ and Rachel E. Sobel⁴, ¹Pediatrics, Seattle Children's Hospital/Univ of Washington, Seattle, WA, ²Rheumatology, Seattle Children's Research Institute, Seattle, WA, ³Pediatrics, Seattle Childrens Hospital, Seattle, WA, ⁴Epidemiology, Worldwide Safety Strategy, Pfizer, Inc., New York, NY
Background/Purpose: There are few data available regarding the rates of serious and important medical events (SAEs and IMEs) for most of the medications used to…
Abstract Number: 904 • 2012 ACR/ARHP Annual Meeting
Perinatal Characteristics, Maternal Reproductive History and Juvenile Idiopathic Arthritis: A Case-Control Study
Samantha W. Bell¹, Beth A. Mueller¹, J. Lee Nelson², Parveen Bhatti¹ and Susan Shenoi³, ¹Epidemiology and Public Health, University of Washington, Seattle, WA, ²Immunogenetics D2-100, Fred Hutchinson Cancer Rsch, Seattle, WA, ³Pediatric Rheumatology, Seattle Children's Hospital, University of Washington, Seattle, WA
Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is a heterogeneous group of chronic inflammatory arthritis conditions in children with onset before 16 years of age, and is the…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].